ReviewExpert reviews in molecular medicine2026
Targeting CD39 as a Therapeutic for Cancer Immunotherapy.
Zhongliang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewExpert reviews in molecular medicine2026
Zhongliang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.